High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households /Fritz, Matthieu Rosolen, B. Krafft, E. /Becquart, Pierre /Elguero, Eric Vratskikh, O. Denolly, S. Boson, B. Vanhomwegen, J. Gouilh, M. A. Kodjo, A. Chirouze, C. Rosolen, S. G. Legros, V. /Leroy, Eric SARS-CoV-2 COVID-19 Pets Seroprevalence One health Luminex Neutralization assay In a survey of household cats and dogs of laboratory-confirmed COVID-19 patients, we found a high seroprevalence of SARS-CoV-2 antibodies, ranging from 21% to 53%, depending on the positivity criteria chosen. Seropositivity was significantly greater among pets from COVID-19+ households compared to those with owners of unknown status. Our results highlight the potential role of pets in the spread of the epidemic. 2020 text https://www.documentation.ird.fr/hor/fdi:010080578 fdi:010080578 Fritz Matthieu, Rosolen B., Krafft E., Becquart Pierre, Elguero Eric, Vratskikh O., Denolly S., Boson B., Vanhomwegen J., Gouilh M. A., Kodjo A., Chirouze C., Rosolen S. G., Legros V., Leroy Eric. High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households. 2020, 11, 100192 [5 ] EN FRANCE FRANCHE COMTE RHONE ALPES